Right‐sided heart failure and tricuspid regurgitation are common and strongly associated
with poor quality of life and an increased risk of heart failure hospitalizations and death …

Pulmonary arterial hypertension (PAH) is a complex disease of multifactorial origin. While
registries have demonstrated that women are more susceptible to the disease, females with …

Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Pulmonary hypertension worsens outcome in left heart disease. Stiffening of the pulmonary
artery may drive this pathology by increasing right ventricular dysfunction and lung vascular …

Cannabidiol (CBD) is a non-intoxicating compound of Cannabis with anti-fibrotic properties.
Pulmonary hypertension (PH) is a disease that can lead to right ventricular (RV) failure and …

Pulmonary hypertension (PH) is a disease of pulmonary artery stenosis and blockage
caused by abnormal pulmonary artery smooth muscle cells (PASMCs), with high morbidity …

Background Targeting short-term improvements in multicomponent risk scores for mortality
in patients with pulmonary arterial hypertension (PAH) could result in improved long-term …

Background Cardiopulmonary exercise testing (CPET) may provide prognostically valuable
information during follow-up after pulmonary embolism (PE). Our objective was to …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism. Important advances have enabled better understanding …

Pulmonary hypertension (PH) is a progressive, pulmonary vascular disease with high
morbidity and mortality. Unfortunately, the pathogenesis of PH is complex and remains …